UTI Healthcare Fund Regular Plan-IDCW Reinvestment
Mutual Fund Details – Invest Smart, Grow Wealth
Discover a variety of mutual funds tailored to your goals, from equity and debt to hybrid options. Track performance, compare funds, and get expert insights to make informed investment decisions. Grow your wealth with Motilal Oswal’s trusted mutual fund solutions.
Equity, Sectoral-Pharma, Principal at very high risk
1 Year Return 5.9% at 16 Feb 2026 03:47 PM
Fund Details
NAV 215.8726
Sub-Type Sectoral-Pharma
Rating 4
Min. SIP Amount ₹500.0
Fund Age(Year) 26.64
Fund Size(in Crores) 1055.0
Fund Performance
1 Month -0.57%
3 Month -3.46%
6 Month -5.33%
1 Year 5.9%
3 Year 23.93%
5 Year 14.57%
Know This Fund
As on 16 Feb 2026
Investment strategy that balances risk & reward by dividing the investment portfolio among different types of asset classes.
Equity (98.79%) Market Cap Mid Cap 37.45 Large Cap 17.95 Small Cap 43.39 Top Sectors Healthcare 98.17 Services 0.62 Top Holding Divi's Laboratories 2.87 Laxmi Dental 0.27 Ipca Laboratories 2.19 Dr. Reddy's Laboratories 3.46 Acutaas Chemicals 1.15 Dr. Lal Pathlabs 1.07 Emcure Pharmaceuticals 1.04 Krishna Institute 1.7 Ajanta Pharma 7.3 Anthem Biosciences 1.71 Alkem Laboratories 3.66 Biocon 0.7 Orchid Pharma 0.66 Cipla 2.51 Alembic Pharmaceuticals 0.74 Metropolis Healthcare 1.72 Aurobindo Pharma 2.76 Syngene International 0.81 Jupiter Life Line Hospitals 2.91 Glenmark Pharmaceuticals 4.2 Procter & Gamble Health 3.02 Sanofi Consumer Healthcare India 0.97 Jubilant Pharmova 0.83 Apollo Hospitals Enterprise 3.5 Windlas Biotech 1.26 Sai Life Sciences 1.82 Pfizer 1.67 Sudeep Pharma 2.19 Fortis Healthcare 2.82 Global Health 1.96 Lupin 6.02 Max Healthcare Institute 2.62 Sun Pharmaceutical Industries 9.07 Rainbow Children's 0.85 Caplin Point Laboratories 2.44 Viyash Scientific 2.11 Aarti Pharmalabs 0.62 Eris Lifesciences 1.96 Gland Pharma 3.98 Vijaya Diagnostic Centre 1.09 Cohance Lifesciences 1.5 Marksans Pharma 1.48 Aster DM Healthcare 1.6
Debt & Others (1.21%) Sector Allocation CBLO 0.01 Net Current Assets 1.2 Debt Credit Ratings Debt Category Others 1.21
Comparison with same funds
Equity, Flexi Cap funds Aditya Birla Sun Life Pharma & Healthcare Fund Regular-Growth Ret 1M -0.94% Ret 1Y 5.79% Ret 3Y 22.15% Ret 5Y 13.29%
Equity, Flexi Cap funds Aditya Birla Sun Life Pharma & Healthcare Fund Regular-IDCW Ret 1M -0.94% Ret 1Y 5.79% Ret 3Y 22.15% Ret 5Y 13.29%
Equity, Flexi Cap funds Aditya Birla Sun Life Pharma & Healthcare Fund Regular-IDCW Reinvestment Ret 1M -0.94% Ret 1Y 5.79% Ret 3Y 22.15% Ret 5Y 13.29%
Equity, Flexi Cap funds Bajaj Finserv Healthcare Fund Regular-Growth Ret 1M -1.82% Ret 1Y 3.4% Ret 3Y 0% Ret 5Y 0%
Equity, Flexi Cap funds Bajaj Finserv Healthcare Fund Regular-IDCW Payout Ret 1M -1.82% Ret 1Y 3.4% Ret 3Y 0% Ret 5Y 0%
Equity, Flexi Cap funds Bajaj Finserv Healthcare Fund Regular-IDCW Reinvestment Ret 1M -1.82% Ret 1Y 3.4% Ret 3Y 0% Ret 5Y 0%
Equity, Flexi Cap funds Bandhan BSE Healthcare Index Fund Regular-Growth Ret 1M -1.78% Ret 1Y 3.3% Ret 3Y 0% Ret 5Y 0%
Equity, Flexi Cap funds Bandhan Healthcare Fund Regular - Growth Ret 1M -2.11% Ret 1Y 0% Ret 3Y 0% Ret 5Y 0%
Equity, Flexi Cap funds Bandhan Healthcare Fund Regular - IDCW Ret 1M -2.11% Ret 1Y 0% Ret 3Y 0% Ret 5Y 0%
Equity, Flexi Cap funds Bandhan Healthcare Fund Regular - IDCW Reinvestment Ret 1M -2.11% Ret 1Y 0% Ret 3Y 0% Ret 5Y 0%
Equity, Flexi Cap funds Baroda BNP Paribas Health and Wellness Fund Regular-Growth Ret 1M -1.01% Ret 1Y 0% Ret 3Y 0% Ret 5Y 0%
Charges & Taxes Expense Ratio
Returns are taxed as per your Income Tax Slab.
Expense Ratio (Inclusive of GST): 2.28%
Exit Load 0%
Stamp Duty 0.005%
Fund Management
The various expenses, charges and taxes associated with your Mutual Fund
Kamal Gada
Education Mr. Gada is B.com, CA, CS, & CFA
Experience Prior to joining UTI Mutual Fund he has worked with BPCL as Senior Accounts Officer.
Riskometer
Mutual Fund Investments are subject to market risk. Read all scheme related documents carefully.
Principal at very high risk
AMC and Fund details
Rank (total sets) 11
Date of Incorporation 1999-06-28
Total AUM 2026-01-31
The Scheme Seeks to generate returns from a portfolio of pure debt oriented funds accessed through the diverse investment styles of underlying schemes selected in accordance with the BSLAMC process.